Browsing: Lung

Lung Cancer

ASCO 2023 Top 5 Lung Abstracts Reviewed Jack West, MD

Lung 2 Mins Read7

Dr. Jack West, MD, an associate professor in medical oncology focused on thoracic oncology at the City of Hope Comprehensive…

Osimertinib: Game-Changing Treatment Non-Small Cell Lung Cancer

Lung 5 Mins Read6

In ASCO 2023, the highly anticipated results of the Adora study were unveiled, providing valuable insights into the efficacy and impact…

Unlocking NSCLC Treatments: A Deep Dive into CodeBreaK 200

Lung 14 Mins Read1

Sotorasib, as demonstrated by the CodeBreaK 200 study, is a promising treatment for patients with KRAS G12C-mutated advanced NSCLC, with…

Sunvozertinib: Best-in-Class for NSCLC EGFR Exon20ins Mutation

Lung 1 Min Read19

Caicun Zhou, MD, PhD – Tongji University Shanghai Pulmonary Hospital Sunvozertinib established itself as the leading targeted therapy for NSCLC…

Biomarker Subgroup Analyses Pretreated KRAS G12C-Mutated NSCLC Patients Benefit from Sotorasib

Lung 3 Mins Read4

Ferdinandos Skoulidis, MD, PhD, from the MD Anderson Cancer Center, presented the results of biomarker subgroup analyses from the phase…

Saved by the Scan: Lung Cancer Screening PSA Advertising

Lung 3 Mins Read1

Dr. Atulya Khosla discussed the “Saved by the Scan” public service advertising program initiated by the American Lung Association (ALA)…

Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 Jack West MD – Article

Lung 21 Mins Read5

iFrame is not supported! Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 Jack West…

Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 Jack West MD

Lung 3 Mins Read5

Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 By Jack West, MD, associate professor…

Lung Cancer EGFR: What Are The Latest Advanced Treatments in 2023? Insights from Ravi Salgia MD

Lung 8 Mins Read8

Lung Cancer EGFR: What Are The Latest Advanced Treatments in 2023? Insights from Ravi Salgia MD By Ravi Salgia, MD,…

Latest Clinical Trials in Thoracic Oncology [2023] [Slides] Ravi Salgia, MD

Lung 25 Mins Read5

Lung Cancer Trials: Insights into Latest Clinical Trials in Thoracic Oncology – Expert Analysis from Ravi Salgia, MD By Ravi…

AI Risk Assessment: Sybil A Reliable Deep Learning Model for Predicting Future Lung Cancer Risk

Lung 10 Mins Read2

AI Risk Assessment: Sybil A Reliable Deep Learning Model for Predicting Future Lung Cancer Risk Dr. Florian Fintelmann By Florian…

AI Risk Assessment: Sybil A Reliable Deep Learning Model for Predicting Future Lung Cancer Risk

Lung 10 Mins Read2

iFrame is not supported! AI Risk Assessment: Sybil A Reliable Deep Learning Model for Predicting Future Lung Cancer Risk Dr.…

Lung Cancer Screening Program: Cedars-Sinai Implements a Streamlined Approach by Sara Ghandehari MD

Lung 8 Mins Read5

Lung Cancer Screening Program: Cedars-Sinai Implements a Streamlined Approach by Sara Ghandehari MD Sara Ghandehari, MD Cedars-Sinai is a non-profit…

AI Risk Assessment: Sybil A Reliable Deep Learning Model for Predicting Future Lung Cancer Risk Dr. Florian Fintelmann

Lung 10 Mins Read16

AI Risk Assessment: Sybil A Reliable Deep Learning Model for Predicting Future Lung Cancer Risk Dr. Florian Fintelmann By Florian…

Lung Cancer Screening Program: Cedars-Sinai Implements a Streamlined Approach by Sara Ghandehari MD

Lung 8 Mins Read33

iFrame is not supported! Lung Cancer Screening Program: Cedars-Sinai Implements a Streamlined Approach by Sara Ghandehari MD Sara Ghandehari, MD…

Lung Cancer Screening Program: Cedars-Sinai Implements a Streamlined Approach by Sara Ghandehari MD

Lung 8 Mins Read6

Lung Cancer Screening Program: Cedars-Sinai Implements a Streamlined Approach by Sara Ghandehari MD Sara Ghandehari, MD Cedars-Sinai is a non-profit…

Efficiency and Effectiveness of Cancer Care – 2022 Program: Testing and Early Diagnosis

Lung 1 Min Read2

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…

Timeliness in Cancer Care – 2022 Program: Testing and Early Diagnosis

Lung 1 Min Read0

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…

Goals of Lung Cancer Advocacy – Goals of Lung Cancer Advocacy

Lung 1 Min Read0

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…

Key Players for Lung Cancer Program Success – 2022 Program: Testing and Early Diagnosis

Lung 1 Min Read0

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…

What is Involved in Lung Cancer Screening? – 2022 Program: Testing and Early Diagnosis

Lung 1 Min Read0

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…

Who Should Receive Lung Cancer Screening? – 2022 Program: Testing and Early Diagnosis

Lung 1 Min Read0

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…

Covid and Lung Cancer Screening – 2022 Program: Testing and Early Diagnosis

Lung 1 Min Read0

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…

Diagnosis and Staging of Mesothelioma é—´çš®ç˜¤çš„è¯Šæ–å’Œåˆ†æœŸ East Asian Lung Cancer Video Library

Lung 1 Min Read0

For our Mandarin-speaking community, GRACE is happy to offer updates to our Lung Cancer Video Library translated and voiced by…

Future Approaches to Treating Mesothelioma æ²»ç–—é—´çš®ç˜¤çš„æœªæ¥æ–¹æ³• – East Asian Lung Cancer Library

Lung 1 Min Read0

For our Mandarin-speaking community, GRACE is happy to offer updates to our Lung Cancer Video Library translated and voiced by…

LCMC3 Neoadjuvant Atezolizumab Phase 2 Study

Lung 10 Mins Read1

iFrame is not supported! LCMC3 Neoadjuvant Atezolizumab Phase 2 Study Results What is the LCMC3 (Lung Cancer Mutation Consortium)…

LCMC3 Neoadjuvant Atezolizumab Phase 2 Study

Lung 10 Mins Read1

LCMC3 Neoadjuvant Atezolizumab Phase 2 Study Results What is the LCMC3 (Lung Cancer Mutation Consortium) Trial? So, this is…

T-DXd Interstitial Lung Disease: Controllable? [2022]

Lung 12 Mins Read0

iFrame is not supported! Is Interstitial Lung Disease a Manageable Adverse Event of Trastuzumab T-DXd Deruxtecan Treatment? What is Trastuzumab…

In the Driverâ€™s Seat With EGFR: Application of Mutation Testing to Treatment Selection for NSCLC

Lung 1 Min Read1

With over 55% of cancer patients treated by community oncologists, itâ€™s imperative that community oncologists and pathologists apply a multidisciplinary…

ASCO [2022] Lung Cancer In-Depth Slides: MOASC

Lung 15 Mins Read12

ASCO [2022] Lung Cancer In-Depth Slides: MOASC Dr. Misako Nagasaka’s (thoracic oncology) MOASC Presentation on ASCO (Annual Meeting, American…

ASCO 2022 Lung Cancer Cancer Question & Answer

Lung 1 Min Read2

Question and Answer Session Dr. Misako Nagasaka – ASCO [2022] Lung Cancer In-Depth Slides: MOASC Presentation https://oncologytube.com/v/41320 Misako Nagasaka, MD…

Precision Medicine for All: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in NSCLC

Lung 1 Min Read1

Despite the advances in precision medicine for non-small cell lung cancer (NSCLC), a significant proportion of patients, particularly African American…

T-DXd Interstitial Lung Disease: Controllable Adverse Event?

Lung 12 Mins Read0

Is Interstitial Lung Disease a Manageable Adverse Event of Trastuzumab T-DXd Deruxtecan Treatment? What is Trastuzumab T-DXd? Trastuzumab T-DXd is…